Skip to main content
. 2021 Mar 24;11:6751. doi: 10.1038/s41598-021-86147-9

Figure 7.

Figure 7

Engraftment of human MSCs in vivo by immunohistochemistry for Vimentin. Human MSCs are observed in brown along the periphery of BCP biomaterials or embedded in osteocyte lacunae dispersed throughout the newly formed bone matrix. The majority of cells present are of mouse host origin shown by the blue/purple nuclei. (A) Engraftment is shown in BMSC and CBMSC samples 8 weeks after transplantation of unprimed cells, cells primed with standard osteogenic supplements, cells primed with BMP-4, and cells primed with chondrogenic supplements (blue asterisks indicate the BCP granules). (B) The quantification of Vimentin identification of human cells for all implants, (C) together with consideration for different priming regimes prior to implantation. Data are presented as mean ± SEM. Statistical analysis was by unpaired Student’s t-test for single experimental condition (dot plot) and by two-way ANOVA followed by Holm–Sidak’s multiple comparison test for multiple experimental conditions (histogram). *Significant difference between MSCs of different tissue origin.